According to GlobalData’s analyst consensus forecast, OTX-2002 is projected to have the highest revenue by 2028, with sales of $1.6 billion during that year
Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes
AstraZeneca has acquired all outstanding equity of TeneoTwo in exchange for an upfront payment of $100m.
The two generic drugs have been launched under the brand names Jankey & Sitenali.
Innate to receive $5M milestone payment from AstraZeneca
The abstract is about the cohort A, stage I of the ongoing global phase ? trial that evaluating the safety and efficacy of Catumaxomab in advanced GC patients with peritoneal metastasis
Glofitamab has the potential to offer a readily available, fixed-duration CD20xCD3 bispecific antibody treatment approach for people with aggressive lymphoma
The hybrid congress will take place from 1-4 June in Copenhagen, as well as virtually
The technology was able to identify approximately 32 percent more adenomas than standard colonoscopy procedures
The drug will be available in 600 hospitals and 105 DTPs
Subscribe To Our Newsletter & Stay Updated
